Male factorEnvironmental exposure to metals and male reproductive hormones: circulating testosterone is inversely associated with blood molybdenum
Key Words
Cited by (0)
M.P.D. is a consultant for Genzyme, Omrix, Neomend, MedElute, Johnson and Johnson, Serono, Kytogenics, Takeda, ARC Pharmaceutical, and Synthemed; has a financial interest in Conceptus, Synthemed, and Advanced Reproductive Care; has received grant support from Johnson and Johnson, Boehringer Ingelheim, Serono, Jackson Laboratory, Meditrina Pharmaceuticals, Neurocrine Biosciences, National Institutes of Health, Department of Veterans Affairs, and Wyeth. E.P. has received research funding from Ferring; is on the Evista advisory board for Eli Lilly; and is a speaker and has participated in multicenter trials for Wyeth. J.D.M. has nothing to disclose. M.G.R. has nothing to disclose. B.P. has nothing to disclose. V.P. has nothing to disclose. D.D. has nothing to disclose. N.P. has nothing to disclose. J.J.W. has nothing to disclose.
Supported by grant ES11856 from the National Institute of Environmental Health Sciences, National Institutes of Health. J.D.M. is supported by a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute.